Mochida Pharmaceutical Co (TSE:4534) EV-to-Revenue : 0.70 (As of May. 03, 2024)

View and export this data going back to 1963. Start your Free Trial

What is Mochida Pharmaceutical Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Mochida Pharmaceutical Co's enterprise value is 円69,682 Mil. Mochida Pharmaceutical Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was 円100,085 Mil. Therefore, Mochida Pharmaceutical Co's EV-to-Revenue for today is 0.70.

The historical rank and industry rank for Mochida Pharmaceutical Co's EV-to-Revenue or its related term are showing as below:

TSE:4534' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.48 Med: 1.01 Max: 1.66
Current: 0.7

During the past 13 years, the highest EV-to-Revenue of Mochida Pharmaceutical Co was 1.66. The lowest was 0.48. And the median was 1.01.

TSE:4534's EV-to-Revenue is ranked better than
87.41% of 1025 companies
in the Drug Manufacturers industry
Industry Median: 2.36 vs TSE:4534: 0.70

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-03), Mochida Pharmaceutical Co's stock price is 円3190.00. Mochida Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was 円2,771.58. Therefore, Mochida Pharmaceutical Co's PS Ratio for today is 1.15.

Mochida Pharmaceutical Co EV-to-Revenue Historical Data

The historical data trend for Mochida Pharmaceutical Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mochida Pharmaceutical Co EV-to-Revenue Chart

Mochida Pharmaceutical Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

EV-to-Revenue

Get a 7-Day Free Trial

1.49

0.99

0.98

0.71

0.60

Mochida Pharmaceutical Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															0.64	0.60	0.64	0.71	0.73

Competitive Comparison of Mochida Pharmaceutical Co's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Mochida Pharmaceutical Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mochida Pharmaceutical Co's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mochida Pharmaceutical Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Mochida Pharmaceutical Co's EV-to-Revenue falls into.

Mochida Pharmaceutical Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Mochida Pharmaceutical Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	69682.314	/	100085
	=	0.70

Mochida Pharmaceutical Co's current Enterprise Value is 円69,682 Mil.
Mochida Pharmaceutical Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円100,085 Mil.

Mochida Pharmaceutical Co (TSE:4534) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Mochida Pharmaceutical Co's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	3190.00	/	2771.582
	=	1.15

Mochida Pharmaceutical Co's share price for today is 円3190.00.
Mochida Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円2,771.58.

Mochida Pharmaceutical Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Mochida Pharmaceutical Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Mochida Pharmaceutical Co (TSE:4534) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mochida Pharmaceutical Co Ltd (TSE:4534) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

1-1 Ichigayahonmuracho, Shinjuku-ku, Tokyo, JPN, 162-0845

Website

http://www.mochida.co.jp

Mochida Pharmaceutical Co Ltd is a major drug manufacturing company that operates in the field of medical care through its pharmaceuticals, healthcare products, and medical equipment businesses. The company's pharmaceuticals business aims to develop and market a broad spectrum of innovative new drugs. One of Mochida's main objectives is to maximize the business performance of its drugs after they are developed and released. The company also creates skin care products for the general public, and these are supplied through pharmacies, drugstores, and mail-order sales.

Mochida Pharmaceutical Co (TSE:4534) Headlines

No Headlines